Impact of Glycemic Control on Penile Duplex Results

StatusUnknown
PhaseNot specified
Started

Record status This record was last updated September 19, 2024 (before its estimated January 2025 completion). Its status may not reflect the trial's current state.

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
  2. Start date: Mar 2024 to Jan 2025v4
  3. Start date: Jan 2024 to Mar 2024v3
  4. Re-verified, no change to tracked fieldsv2
  5. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Assiut University
1,667 trials monitored
See 15 trials at risk
Diabetes
5,101 trials monitored
See 233 trials at risk
The study aimed at evaluating the impact of glycemic control on the erectile function , penile Doppler, and cavernosal blood NO and glutathione levels among a group of diabetic patients with erectile dysfunction.
Trial Details
NCT Number NCT06220968
Lead Sponsor Assiut University
Conditions
(from sponsor)		 Erectile Dysfunction With Diabetes Mellitus
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov